Analysis of Fes kinase activity in myeloid cell growth and differentiation

Stem Cells

Volumn 14, Issue 6, 1996, Pages 714-724

  Yates, Karen E ^a   Crooks, Gay M ^b   Gasson, Judith C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

C Fes; Cytokine; Myeloid cells; Signal transduction; Tyrosine kinase

Indexed keywords

DNA; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; PROTEIN KINASE FES; PROTEIN TYROSINE KINASE; RECOMBINANT ALPHA2A INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LYSATE; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0029853231     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140714     Document Type: Article

References (43)

1. Ferrari S, Torelli U, Selleri L et al. Expression of human c-fes onc-gene occurs at detectable levels in myeloid but not in lymphoid cell populations. Br J Haematol 1985;59:21-25.
2. Lanfrancone L, Mannoni P, Pebusque MJ et al. Expression pattern of c-fes oncogene mRNA in human myeloid cells. Int J Cancer 1989;4:35-38.
3. Care A, Mattia G, Montesoro E et al. c-fes expression in ontogenetic development and hematopoietic differentiation. Oncogene 1994;9:739-747.
4. Greer P, Haigh J, Mbamalu G et al. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 1994;14:6755-6763.
5. Slamon DJ, deKernion JB, Verma IM et al. Expression of cellular oncogenes in human malignancies. Science 1984;224:256-262.
6. Smithgall TE, Johnston JB, Bustin M et al. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification. J Natl Cancer Inst 1991;83:42-46.
7. Brach MA, Gauer E, Ludwig W-D et al. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously. Int J Cell Cloning 1991;9:89-94.
8. Jucker M, Roebroek AJM, Mautner J et al. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. Oncogene 1992;7:943-952.
9. Nishio H, Nakamura S-I, Horai T et al. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer. Cancer 1991;69:1130-1136.
10. Hanazono Y, Chiba S, Sasaki K et al. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 1993;81:3193-3196.
11. Smithgall TE, Yu G, Glazer RI. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J Biol Chem 1988;263:15050-15055.
12. Goldman J, McGuire WA. Oncogene RNA expression in three human lymphoblastic leukemia cell line lymphocytes. Pediatr Hematol Oncol 1992;9:57-63.
13. Fumagalli S, Volpi L, Rossi D et al. Activation of c-fos and c-fes in metastatic lympho-macrophage hybrids. Int J Cancer 1992;52:478-482.
14. Hanazono Y, Chiba S, Sasaki K et al. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J 1993;12:1641-1646.
15. Miyajima A. Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning 1992;10:126-134.
16. c subunit that signals DNA synthesis in NIH 3T3 cells specifically binds a complex of Src and Janus family tyrosine kinases and phosphatidylinositol 3-kinase. J Biol Chem 1995;270:6886-6893.
17. Brizzi MF, Aronica MG, Rosso A et al. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p19, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem 1996;271:3562-3567.
18. Quelle FW, Sato N, Witthuhn BA et al. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 1994;14:4335-4341.
19. Witthuhn BA, Quelle FW, Silvennoinen O et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993;74:227-236.
20. Linnekin D, Mou SM, Greer P et al. Phosphorylation of a Fes-related protein in response to granulocyte-macrophage colony-stimulating factor. J Biol Chem 1995;270:4950-4954.
21. Matsuda T, Fukada T, Takahashi-Tezuka M et al. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J Biol Chem 1995;270:11037-11039.
22. Izuhara K, Feldman RA, Greer Pet al. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J Biol Chem 1994;269:18623-18629.
23. Ferrari S, Manfredini R, Tagliafico E et al. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation. Leukemia 1994;1:S91-S94.
24. Ferrari S, Donelli A, Manfredini R et al. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell Growth Differ 1990;1:543-548.
25. Manfredini R, Grande A, Tagliafico E et al. Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J Exp Med 1993;178:381-389.
26. c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells. Biochemistry 1993;32:6995-7001.
27. Yu G, Smithgall TE, Glazer RI. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J Biol Chem 1989;264:10276-10281.
28. Sawyers CL, McLaughlin J, Goga A et al. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 1994;77:121-131.
29. lck in thymopoiesis. EMBO J 1993;12:1671-1680.
30. Yates KE, Lynch MR, Wong SG et al. Human c-FES is a nuclear tyrosine kinase. Oncogene 1995;10:1239-1242.
31. Muller AJ, Young JC, Pendergast A-M et al. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 1991;11:1785-1792.
32. Krishan A. Rapid flow cytofluorometer analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975;66:188-193.
33. gag-fps is essential for protein-tyrosine kinase activity. EMBO J 1986;5:69-86.
34. src. Mol Cell Biol 1986;6:751-757.
35. Kitamura T, Tange T, Terasawa T et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, erythropoietin. J Cell Physiol 1989;140:323-334.
36. Ronco LV, Doyle SE, Raines M et al. Conserved amino acids in the human granulocyte- macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation. J Immunol 1995;154:3444-3453.
37. Sakamaki K, Miyajima I, Kitamura Y et al. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 1992;11:3541-3549.
38. fyn. Cell 1992;70:751-763.
39. Soriano P, Montgomery C, Geske R et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
40. Grant SGN, O'Dell TJ, Karl KA et al. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 1992;258:1903-1910.
41. Stein PL, Vogel H, Soriano P. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev 1994;8:1999-2007.
42. Lowell CA, Soriano P, Varmus HE. Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. Genes Dev 1994;8:387-398.
43. Lowell CA, Niwa M, Soriano P et al. Deficiency of Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Blood 1996;87:1780-1792.